Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9699580 | 0.77 | KMT2A (0.52) | L3MBTL1LMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL677668 | 0.74 | LMNA (0.46) | L3MBTL1LMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL11251562 | 0.72 | ACHE (0.48) | LMNAMEN1KMT2AHTTALDH1A1 | |
| SCHEMBL3658311 | 0.72 | CHRM5 (0.52) | LMNAMEN1KMT2ASMN1; SMN2TSHR | |
| SCHEMBL27665984 | 0.72 | L3MBTL1 (0.40) | L3MBTL1LMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL30496487 | 0.72 | CYP2A6 (0.42) | L3MBTL1LMNAMEN1KMT2ASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL4552761 | 0.72 | LMNA (0.45) | L3MBTL1LMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL4642647 | 0.72 | L3MBTL1 (0.40) | L3MBTL1LMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL7406305 | 0.72 | ALDH1A1 (0.52) | L3MBTL1MEN1KMT2ATSHRHTT | |
| Benzene SCHEMBL22658153 | 0.71 | ALDH1A1 (0.56) | L3MBTL1LMNAMEN1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1153100-A1 | PHOTOCHROMATIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN POLYMERIC MATERIALS | Great Lakes Chemical (Europe) GmbH (CH) | 2001-11-14 | — | — | EP | claimed |
| WO-2000039245-A1 | PHOTOCHROMATIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN POLYMERIC MATERIALS | GREAT LAKES CHEMICAL (EUROPE) GMBH (CH) | 2000-07-06 | — | — | WO | claimed |
| CN-115611882-B | Fluorescent compound and preparation method and application thereof | 深圳大学 | 2024-07-09 | — | — | CN | disclosed |
| US-20170073359-A1 | Optically-Detectable Enzyme Substrates and Their Method of Use | MOLECULAR PROBES, INC. | 2017-03-16 | — | — | US | disclosed |
| WO-2017005412-A1 | METHOD FOR SYNTHESISING ALIPHATIC AND AROMATIC AMIDES | CLARIANT INTERNATIONAL LTD (CH) | 2017-01-12 | — | — | WO | disclosed |
| US-20160139135-A1 | Optically-Detectable Enzyme Substrates and Their Method of Use | LIFE TECHNOLOGIES CORP (US) | 2016-05-19 | — | — | US | disclosed |
| US-9039870-B2 | Method for producing alkaline (meth)acrylamides | CLARIANT FINANCE (BVI) LIMITED (VG) | 2015-05-26 | — | — | US | disclosed |
| EP-2448914-B1 | CONTINUOUS METHOD FOR PRODUCING AMIDES OF AROMATIC CARBOXYLIC ACIDS | CLARIANT FINANCE BVI LTD (VG) | 2014-11-26 | — | — | EP | disclosed |
| US-8884040-B2 | Continuous method for producing fatty acid amides | CLARIANT FINANCE (BVI) LIMITED (VG) | 2014-11-11 | — | — | US | disclosed |
| US-8865891-B2 | Optically-detectable enzyme substrates and their method of use | Life Technologies Corporation (US) | 2014-10-21 | — | — | US | disclosed |
| EP-2448915-B1 | CONTINUOUS METHOD FOR PRODUCING AMIDES OF ALIPHATIC CARBOXYLIC ACIDS | CLARIANT FINANCE BVI LTD (VG) | 2013-12-04 | — | — | EP | disclosed |
| US-20090149652-A1 | Derivatives of 4-aminopiperidine and their use as a medicament | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES | 2009-06-11 | — | — | US | disclosed |
| US-20090047692-A1 | OPTICALLY-DETECTABLE ENZYME SUBSTRATES AND THEIR METHOD OF USE | INVITROGEN CORPORATION (US) | 2009-02-19 | — | — | US | disclosed |
| WO-2008117175-A2 | NOVEL BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE | ADDEX PHARMA SA (CH) | 2008-10-02 | — | — | WO | disclosed |
| US-7393861-B2 | Derivatives of 4-aminopiperidine and their use as a medicament | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 2008-07-01 | — | — | US | disclosed |
| WO-2008043492-A1 | METHOD FOR PRODUCING ALKALINE (METH)ACRYLAMIDES | CLARIANT FINANCE (BVI) LIMITED (VG) | 2008-04-17 | — | — | WO | disclosed |
| US-20070060575-A1 | Aspartyl protease inhibitors | MERCK SHARP & DOHME LLC | 2007-03-15 | — | — | US | disclosed |
| US-20050227309-A1 | Optically-detectable enzyme substrates and their method of use | MOLECULAR PROBES, INC. | 2005-10-13 | — | — | US | disclosed |
| US-5506347-A | ADENOSINE KINASE INHIBITOR | GENSIA, INC. (US) | 1996-04-09 | — | — | US | disclosed |
| US-5106716-A | Polymer grains dispersed in non-aqueous solvent | FUJI PHOTO FILM CO., LTD. (JP) | 1992-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090149652-A1 | Derivatives of 4-aminopiperidine and their use as a medicament | SSTR4, SSTR3, SSTR1 | L3MBTL1 3893/4885LMNA 3780/4885MEN1 1998/4885 |
| US-20070060575-A1 | Aspartyl protease inhibitors | CHRM2, BACE1, CHRM1 | L3MBTL1 652/4885LMNA 1839/4885MEN1 1382/4885 |
| US-20160139135-A1 | Optically-Detectable Enzyme Substrates and Their Method of Use | MGAM, LCT, GAA | L3MBTL1 443/4885LMNA 629/4885MEN1 3638/4885 |
| US-20170073359-A1 | Optically-Detectable Enzyme Substrates and Their Method of Use | MGAM, LCT, GAA | L3MBTL1 443/4885LMNA 629/4885MEN1 3638/4885 |
| US-20090047692-A1 | OPTICALLY-DETECTABLE ENZYME SUBSTRATES AND THEIR METHOD OF USE | MGAM, LCT, GAA | L3MBTL1 443/4885LMNA 629/4885MEN1 3638/4885 |
| US-20050227309-A1 | Optically-detectable enzyme substrates and their method of use | MGAM, LCT, GAA | L3MBTL1 443/4885LMNA 629/4885MEN1 3638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.